HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Hims & Hers Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$28.15+0.08 (+0.29%)
Close on Oct 19, 2026
- Market cap
- $6.52B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$21.63 (−43.45%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Hims & Hers Health, Inc. grew revenue 28.0% to $2.58B over the twelve months to Jun 30, 2026. Operating income fell 223.0% to -$154.52M, moving the operating margin from 6.2% to -6.0%. Free cash flow was $61.55M, down 48.5% from a year earlier.
Revenue
$2.58B
+28.0% vs. a year earlier
Operating income
-$154.52M
-223.0% vs. a year earlier
Free cash flow
$61.55M
-48.5% vs. a year earlier
EPS, diluted
-$0.63
-178.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $6.52B
- P/E ratio
- –
- Price to sales
- 2.53
- Price to book
- 20.13
- Dividend yield
- –
- Free cash flow yield
- 0.94%
Fundamentals
- Revenue
- $2.58B
- Net income
- -$142.03M
- EPS, diluted
- -$0.63
- Free cash flow
- $61.55M
- Book value per share
- $1.40
- Diluted shares
- 232M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
$2.58B+28.0% YoY
Gross profit
$1.76B+15.0% YoY
Operating income
-$154.52M-223.0% YoY
Net income
-$142.03M-173.4% YoY
EPS, diluted
-$0.63-178.8% YoY
Free cash flow
$61.55M-48.5% YoY
Reported periodTrailing twelve months